INS and Hyperglycemia: We were not surprised to find that the proteome and phosphoproteome of EV-enriched preparations were associated with hyperglycemia, insulin treatment and glucose variability as these are key drivers of T1D pathophysiology, but also with T1D pathogenic mechanisms.